Federal Supply Schedule 36F79720D0078
- This is a multiple award Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Mallinckrodt Hospital Products Inc., a foreign-owned for-profit corporation. The $140,039,590 contract has a period of performance from July 15, 2020 to July 31, 2026, and is intended to provide drugs, pharmaceuticals, and hematology-related products to VA medical facilities. Under this FSS contract, Mallinckrodt has previously received firm fixed-price delivery orders from the...
- This Federal Supply Schedule contract, valued at $107,632,940, was awarded by the Department of Veterans Affairs (VA) to Specgx LLC, a foreign-owned pharmaceutical manufacturer doing business as Mallinckrodt Pharmaceuticals. The contract is for the provision of drugs, pharmaceuticals, and hematology-related products (FSS Contract 65 I B) to support the VA healthcare system and its associated Veterans Integrated Service Networks (VISNs). Under this Federal Supply Schedule, Specgx has received...
- This Federal Supply Schedule (FSS) contract V797D-70231 was awarded by the Department of Veterans Affairs (VA) to Mylan Institutional Inc. to provide pharmaceutical and hematology-related products. The contract has a ceiling value of $37,353,260.00 and runs through September 29, 2026. Under this FSS contract, a single task order (V797D70231|75P00220F80029) valued at $10,123.94 was issued by the Office of the Assistant Secretary for Administration, a civilian agency, to procure unspecified...
- Merck Sharp & Dohme LLC has been awarded a Federal Supply Schedule contract by Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs, for the procurement of drugs, pharmaceuticals, and hematology-related products under General Services Administration schedule 61-IB. This multiple-award Indefinite Delivery Vehicle carries a ceiling value of $5.84 billion with a period of performance extending through May 31, 2030, commencing June 1, 2025. The...
- This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA), provides Supernus Pharmaceuticals, Inc. a five-year, $132.6 million ceiling to supply drugs, pharmaceuticals, and hematology-related products to VA medical facilities. As a multiple award schedule (MAS) contract under FSS-61-IB, it allows the VA to directly order pre-negotiated products from Supernus's catalog to efficiently meet the...
- The Federal Supply Schedule (FSS) contract award to Mylan Pharmaceuticals Inc. is for a five-year period, from January 1, 2023 to December 31, 2027, with a total ceiling value of $364,546,690.00. The contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the Department of Veterans Affairs (VA), to provide a full range of drugs and hematology-related products. As the prime contractor, Mylan Pharmaceuticals will supply prescription medications and...
- This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to Glenmark Pharmaceuticals Inc., USA, a foreign-owned, for-profit pharmaceutical company. The $4.9 million multiple award contract, valid through October 2027, is for the provision of drugs, pharmaceuticals, and hematology-related products under Schedule 65 IB of the FSS. The contract leverages the VA's Pharmaceutical Prime Vendor program to distribute medications to the patient populations served...
- This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Piramal Critical Care Inc., a child company of Piramal Healthcare, Inc. The contract is for the delivery of pharmaceutical and hematology-related products, with a ceiling value of $6,680,000 and a period of performance through June 30, 2027. The contract was awarded without the use of any set-asides and is a multiple award vehicle, meaning other qualified...
- The Department of Veterans Affairs has awarded Endo USA, Inc. a Federal Supply Schedule (FSS) contract vehicle for Pharmaceuticals and Drugs (FSS-61-IB), with a ceiling value of $264,000,000 and a period of performance extending to March 31, 2026. This multiple-award IDV enables the VA's Veterans Integrated Service Network 12 to procure a range of pharmaceutical and hematology-related products from Endo USA, Inc. to support healthcare services for veteran populations. Additionally, the...
- This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Mylan Specialty LP, a for-profit manufacturer of pharmaceuticals and medical devices. The contract, valued at up to $514,849,130, runs through January 2027 and allows the VA to issue task orders to procure pharmaceuticals, drugs, hematology products, and related medical supplies to serve the healthcare needs of veterans. Specifically, the contract covers National...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79720D0078Federal Supply Schedule
- -Blanket Purchase Agreements
- 3Federal Contract Awards
Mallinckrodt ARD LLC was awarded a multiple-award Federal Supply Schedule (FSS-61-IB) contract by the General Services Administration (GSA) with a $27.9 million ceiling value and a period of performance through March 2026. The contract enables federal customers, such as the Department of Veterans Affairs (VA) and National Institutes of Health (NIH), to procure a range of pharmaceutical and hematology-related products and services through task orders. Under this IDV, Mallinckrodt has fulfilled three delivery orders to date, totaling approximately $60,000, for the NIH Clinical Center and VA Veterans Integrated Service Network 8. These orders, issued against the company's Pharmaceuticals and Drugs FSS contract, provided drug products and Therakos, Inc. items to support patient care, medical research, and related programs at those agencies. The orders ranged from $14,687 to $29,410 and were awarded without any set-aside designations, with performance occurring at Mallinckrodt's facility in Bedminster, New Jersey.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00030 | Add Subcontract Plan | $0 | 4/12/25 | |
| P00027 | Supplemental Agreement for work within scope | $0 | 1/3/25 | |
| P00018 | Other Administrative Action | $0 | 1/2/25 | |
| P00026 | Supplemental Agreement for work within scope | $0 | 12/17/24 | |
| P00025 | Supplemental Agreement for work within scope | $0 | 11/25/24 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36F79720D0078-75N90024F00009 | Mallinckrodt ARD LLC | $14.7k | 11/27/23 | 11/26/24 | 11/27/23 | |
Delivery Order 36F79720D0078-36C24820F0236 | Mallinckrodt ARD LLC | $29.4k | 7/8/20 | 7/31/20 | 7/8/20 | |
Delivery Order 36F79720D0078-75N90024F00014 | Mallinckrodt ARD LLC | $15.9k | 12/6/23 | 12/5/24 | 12/7/23 |